FindTrial
Sign In

Importance of PET CT scan in newly diagnosed multiple myeloma

Prognostic value of PET CT in newly diagnosed multiple myeloma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058861
Enrollment
41
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C900- Multiple myeloma

Interventions

None listed

Sponsors

Pamidi .Kavya Siva Keerthana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed multiple myeloma in Department of Medical Oncology

Exclusion criteria

Exclusion criteria: Patients diagnosed with Monoclonal gammopathy of unknown significance

Design outcomes

Primary

MeasureTime frame
Based on number of focal lesions & SUV max on PET CT with response assessmentTimepoint: To check at time of recuirtment (baseline) and response at end of 4 months—

Secondary

MeasureTime frame
Based on R ISS staging with response assessmentTimepoint: To check at time of recuirtment (baseline) & response at end of 4 months—

Countries

India

Contacts

Public ContactPamidi Kavya Siva Keerthana

Katurba Medical College

ananth.pai@manipal.edu9880239139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026